| Product Code: ETC6352408 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Belgium saw an increase in the concentration of drug-device combination products imports, with Italy, Germany, USA, Metropolitan France, and Switzerland being the top exporting countries. Despite a slight decrease in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) over the period 2020-2024 remained strong at 6.48%. This shift towards moderate concentration indicates a potential trend towards a more competitive market landscape in the coming years, as Belgium continues to be a key destination for these innovative healthcare products.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Drug-Device Combination Products Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Drug-Device Combination Products Market Revenues & Volume, 2022 & 2032F |
3.3 Belgium Drug-Device Combination Products Market - Industry Life Cycle |
3.4 Belgium Drug-Device Combination Products Market - Porter's Five Forces |
3.5 Belgium Drug-Device Combination Products Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Belgium Drug-Device Combination Products Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Belgium Drug-Device Combination Products Market Revenues & Volume Share, By End user, 2022 & 2032F |
4 Belgium Drug-Device Combination Products Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Belgium |
4.2.2 Technological advancements in drug-device combination products |
4.2.3 Growing demand for personalized medicine |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of drug-device combination products |
4.3.2 High development costs associated with innovative products |
5 Belgium Drug-Device Combination Products Market Trends |
6 Belgium Drug-Device Combination Products Market, By Types |
6.1 Belgium Drug-Device Combination Products Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Belgium Drug-Device Combination Products Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Belgium Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting stents, 2022 - 2032F |
6.1.4 Belgium Drug-Device Combination Products Market Revenues & Volume, By Infusion pumps, 2022 - 2032F |
6.1.5 Belgium Drug-Device Combination Products Market Revenues & Volume, By Photodynamic therapy, 2022 - 2032F |
6.1.6 Belgium Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial wound dressings, 2022 - 2032F |
6.1.7 Belgium Drug-Device Combination Products Market Revenues & Volume, By Prefilled syringes, 2022 - 2032F |
6.1.8 Belgium Drug-Device Combination Products Market Revenues & Volume, By Drug-eluting balloons, 2022 - 2032F |
6.1.9 Belgium Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.1.10 Belgium Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.2 Belgium Drug-Device Combination Products Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Belgium Drug-Device Combination Products Market Revenues & Volume, By Cardiovascular Disorders, 2022 - 2032F |
6.2.3 Belgium Drug-Device Combination Products Market Revenues & Volume, By Diabetes, 2022 - 2032F |
6.2.4 Belgium Drug-Device Combination Products Market Revenues & Volume, By Respiratory Problems, 2022 - 2032F |
6.2.5 Belgium Drug-Device Combination Products Market Revenues & Volume, By Cancer Treatment, 2022 - 2032F |
6.2.6 Belgium Drug-Device Combination Products Market Revenues & Volume, By Antimicrobial Application, 2022 - 2032F |
6.2.7 Belgium Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
6.3 Belgium Drug-Device Combination Products Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Belgium Drug-Device Combination Products Market Revenues & Volume, By Hospital & clinic, 2022 - 2032F |
6.3.3 Belgium Drug-Device Combination Products Market Revenues & Volume, By Ambulatory surgery center (asc), 2022 - 2032F |
6.3.4 Belgium Drug-Device Combination Products Market Revenues & Volume, By Home care setting, 2022 - 2032F |
6.3.5 Belgium Drug-Device Combination Products Market Revenues & Volume, By Other, 2022 - 2032F |
7 Belgium Drug-Device Combination Products Market Import-Export Trade Statistics |
7.1 Belgium Drug-Device Combination Products Market Export to Major Countries |
7.2 Belgium Drug-Device Combination Products Market Imports from Major Countries |
8 Belgium Drug-Device Combination Products Market Key Performance Indicators |
8.1 Adoption rate of drug-device combination products by healthcare providers |
8.2 Number of clinical trials conducted for new drug-device combination products |
8.3 Rate of reimbursement for drug-device combination products by healthcare payers |
9 Belgium Drug-Device Combination Products Market - Opportunity Assessment |
9.1 Belgium Drug-Device Combination Products Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Belgium Drug-Device Combination Products Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Belgium Drug-Device Combination Products Market Opportunity Assessment, By End user, 2022 & 2032F |
10 Belgium Drug-Device Combination Products Market - Competitive Landscape |
10.1 Belgium Drug-Device Combination Products Market Revenue Share, By Companies, 2025 |
10.2 Belgium Drug-Device Combination Products Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here